NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

September 5, 2024

Study Completion Date

March 5, 2025

Conditions

Heart Failure

Interventions

DRUG

HiCM-188 therapy

Epicardial Injection of Allogeneic Human Pluripotent Stem Cell-derived Cardiomyocytes (HiCM-188) during coronary artery bypass grafting surgery

Trial Locations (1)

RECRUITING

TEDA International Cardiovascular Hospital, Tianjin